The maker of Advil, Tums and Sensodyne toothpaste is investing $54.2 million to upgrade its global research and development facility in Richmond. Why it matters: The upgrades could lead to more local ...

Governor Glenn Youngkin announced on Monday that a global healthcare company will be expanding its research and development facility located in the City of Richmond.

The consumer health company site will launch an internship program with the state government and Virginia Commonwealth University ...

Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new product ...

Haleon, a global company behind home healthcare products like Advil, Tums and Aquafresh, announced plans to upgrade its Richmond research and development facility.

Haleon, an international manufacturer of medicine, vitamins and toothpaste, will upgrade its lab in Richmond’s North Side at a cost of $54 million, the company announced Monday. Based in England ...

The UK-based pharmaceutical company Haleon will invest $54.2 million to upgrade its R&D facility in Richmond, which has helped birth or grow products such as Advil, Emergen-C and Robitussin.

RICHMOND, Va. (WRIC) — Haleon, a global consumer health company behind products like Advil, Aquafresh and Polident, announced a $54.2 million upgrade to its Richmond facility. On Monday ...

Consumer health care company Haleon plans to invest $54.2 million to upgrade its research and development facility in Richmond’s Northside.

Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new product ...

The modernization will enable the company to accommodate innovative technologies and expand its research capabilities. Governor Youngkin met with Haleon leadership in London in July 2024 to discuss ...